A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

The MyHPVscore test represents a successful translation of research from the laboratory to clinical practice. A Michigan ...

Reduced-dose radiotherapy in head & neck cancer shows similar efficacy to standard dose but with lower toxicity, per findings ...

An immunotherapy treatment has been found to ‘change the world’ for head and neck cancer patients by giving them an extra two and a half years before the disease worsens or comes back.

New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, affecting over half a million people each year and causing about 300,000 ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...